RPS26P52

Across TCGA pan-cancer cohorts, RPS26P52 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPS26P52 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPS26P52 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS26P52 expression acts as an unfavorable survival marker, although some lineages such as LUAD and SKCM show a favorable association.

BLCA, LUSC, and LUAD are the cancer types where RPS26P52 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Quartile	All	0.500	0.645	<.001	62	view →
LUSC	OS	Tertile	II,III,IV	0.436	0.887	<.001	44	view →
LUAD	OS	Quartile	All	0.476	0.330	.003	37	view →
CHOL	DFS	Quartile	II,III,IV	0.096	0.606	.009	34	view →
SKCM	OS	Median	IV	1.000	0.257	.001	32	view →
MESO	DFS	Tertile	IV	0.117	0.469	<.001	21	view →
UVM	DFS	Quartile	All	0.410	0.824	.006	18	view →
KIRC	DFS	Quartile	III,IV	0.321	0.549	.010	16	view →
DLBC	DFS	Tertile	II,III,IV	0.433	0.944	.008	15	view →
THCA	OS	Tertile	IV	0.601	0.940	.011	12	view →
THYM	OS	Quartile	All	0.881	1.000	.014	6	view →
STAD	DFS	Median	IV	0.562	0.157	.019	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPS26P52–BLCA (DFS)

Open the BLCA breakdown →